Threes, the PPHM needle is at 0.54$ as we speak.
Whatever RONIN did it has NO sustainable effect; Just like the 5$ of PPHM in 2012 wasn't sustained due to dose switching, just like many peaks to 2* (pre-RS) didn't stay, etc.
RONIN bought in a position and that increased the PPS then just BEFORE the RS it lowered, after the neutral RS it got up and then RONIN communicated his first letter and since then we are deep down back to the about 0.50$ cent level pre-split.
If the market believe that RONIN would get 100% control the next ASM, then do a sell out that would bring EVEN ONLY 14$ per share (that 2$ pre-RS) then we would at this point BE UP BIG TIME ALREADY. The market just doesn't belive in that scenario and in the past we were ALWAYS told that the market is always right when the PPHM PPS sunk. I figure this is also true when it doesn't go up or is that proverb only one way,
I think we will KEEP GOING UP (SPECULATION) but slowly while something might be coming. But I also think it will have nothing to do with RONIN.
Peregrine Pharmaceuticals the Microsoft of Biotechnology! All In My Opinion. I am not advising anything, nor accusing anyone.